The present invention discloses the use of inhibitors and/or antagonists of PACAP signalling for the manufacture of a medicament for the prevention or treatment of decreased blood platelet numbers (thrombocytopenia).

 
Web www.patentalert.com

< Compositions of NDV and methods of use thereof for treatment of cancer

> Substituted pyrrolidinones, their manufacture and their use as medicaments

> Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
~ 00558